GlassScriptPhysician profile
Jennifer L Schaefer
NPI 1669468484
$1,851.04
in general payments reported to CMS, 2019-2025
23 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $165 · 2021: $150 · 2022: $296 · 2023: $227 · 2024: $274 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722 · Education: $53.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.45 |
| Education | $53.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $283.29 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Coopersurgical, INC. | $281.21 | 2019-2025 | Paragard T 380a, Paragard T 380a, Summit Doppler |
| Hologic Sales and Service, LLC | $227.03 | 2019-2025 | Myosure Tissue Removal Device, Novasure, Aptima |
| Pfizer INC. | $207.36 | 2019-2023 | |
| Myovant Sciences INC. | $114.87 | 2021-2022 | |
| Aspira Women'S Health INC | $91.51 | 2022 | |
| Biogen, INC. | $78.73 | 2025 | Zurzuvae |
| Millicent US INC | $74.96 | 2024 | Intrarosa, Femring |
| Therapeuticsmd, INC. | $64.20 | 2019-2020 | |
| Astellas Pharma US INC | $61.45 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $47.56 | 2020-2024 | |
| Mayne Pharma Commercial LLC | $38.67 | 2024-2025 | |
| Amgen INC. | $37.40 | 2019 | |
| Avion Pharmaceuticals | $35.66 | 2019-2023 | Balcoltra |
| Convatec INC. | $33.69 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $27.87 | 2023 | Myfembree |
| Becton, Dickinson and Company | $26.08 | 2022 | |
| Allergan, INC. | $23.57 | 2019 | |
| Hologic INC | $21.43 | 2021 | |
| Dermira, INC. | $21.42 | 2020 | |
| Gynesonics, INC. | $21.09 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exeltis, USA INC. | $16.39 | 2025 | Slynd |
| Ferring Pharmaceuticals INC. | $15.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.